Proceedings of the 1st World Conference on Health and Social Science (WCHSS 2022)

The Effect of Spirizomacare Therapy on Anxiety Level in Hypertension Patients

Authors
Meynur Rohmah1, *, Ayu Pratiwi1, Yunike Edmaningsih1
1Universitas Yatsi Madani, Tangerang, Indonesia
*Corresponding author. Email: meynurrohmah@uym.ac.id
Corresponding Author
Meynur Rohmah
Available Online 14 June 2023.
DOI
10.2991/978-94-6463-186-9_12How to use a DOI?
Keywords
Hypertension; Anxiety; Spirizomacare Therapy
Abstract

In hypertensive patients who experience anxiety, their blood pressure will increase which causes them to be more susceptible to complications of hypertension, so it is important to pay attention to mental health conditions in hypertensive patients. Purpose: to determine the effectiveness of Spirizomacare on anxiety levels in patients with hypertension and as a preliminary study for a form of activity that can reduce anxiety levels in patients with hypertension. Methods: This research design uses pre-experimental research with one group pretest-posttest research design, 2 times. The research location is the Grogol Health Center. The study was conducted in June-September 2022. The method of selecting the research sample was using a purposive sampling method using 30 respondents. Techniques of data analysis using univariate and bivariate analysis with paired T-test. The results showed that there was an effect of spirizomacare therapy on the level of anxiety in hypertensive patients, with a p-value of 0.000 < 0.05. Conclusion: The spiritual remembrance approach is carried out with the concept of changing the anxiety caused by the fear of death. In this study, it was found that there was a decrease in the level of anxiety in hypertensive patients at the Grogol Health Center. Suggestion: For nursing management as a reference to overcome anxiety levels in hypertensive patients and provide health education to all patients about controlling anxiety. So it is hoped that there will be no severe anxiety in patients with hypertension.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the 1st World Conference on Health and Social Science (WCHSS 2022)
Series
Advances in Health Sciences Research
Publication Date
14 June 2023
ISBN
978-94-6463-186-9
ISSN
2468-5739
DOI
10.2991/978-94-6463-186-9_12How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Meynur Rohmah
AU  - Ayu Pratiwi
AU  - Yunike Edmaningsih
PY  - 2023
DA  - 2023/06/14
TI  - The Effect of Spirizomacare Therapy on Anxiety Level in Hypertension Patients
BT  - Proceedings of the 1st World Conference on Health and Social Science (WCHSS 2022)
PB  - Atlantis Press
SP  - 86
EP  - 91
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-186-9_12
DO  - 10.2991/978-94-6463-186-9_12
ID  - Rohmah2023
ER  -